Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice
Food & Function · 2025
DOI: 10.1039/d5fo03751d ↗At a glance
Journal article in Food & Function, 2025. Written by Leyan Zhou and 9 co-authors. Institution: Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. …. Major MEDLINE topics: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Soybean Proteins. Cited 2 times so far (Crossref); 79 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (original language)
Aglycin alleviates NAFLD by modulating gut microbiota composition, restoring intestinal barrier function, and reducing hepatic inflammation.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. zhaomin1986zm@126.com.
- School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
- College of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi, China.
- Zhong Shi Du Qing (Shandong) Biotechnology Company, Heze, 274108, Shandong, China.
- Center for Experimental Public Health and Preventive Medicine Education, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
- Nutrilite Health Institute, Shanghai, 201203, China. Hudson.wu@amway.com.
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Cite
APA
Zhou, L., Li, J., Wei, W., Ma, X., Xu, Z., Ouyang, L., Guan, Y., Jia, X., Wu, Q., & Zhao, M. (2025). Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice. Food & Function. https://doi.org/10.1039/d5fo03751d
Vancouver
Zhou L, Li J, Wei W, Ma X, Xu Z, Ouyang L, et al. Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice. Food & Function. 2025. doi:10.1039/d5fo03751d
BibTeX
@article{Zhou2025,
author = {Zhou, Leyan and Li, Juan and Wei, Wei and Ma, Xiaomin and Xu, Zhuyan and Ouyang, Limin and Guan, Yutong and Jia, Xue and Wu, Qiming and Zhao, Min},
title = {Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice},
journal = {Food & Function},
year = {2025},
doi = {10.1039/d5fo03751d}
}
EUVIMED